ArticleFrontiers in nutrition2026
Plant-based caloric restriction diets versus conventional calorie-restricted diets for weight loss and metabolic health in obese adults: a 12-week randomized, open-label, non-inferiority trial.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Plant-based caloric restriction diet (PB-CRD), combining plant-based nutrition with intermittent caloric restriction, represent a structured dietary strategy to obesity management. This study compared the effects of PB-CRD and calorie-restricted diet (CRD) on weight loss, and metabolic health, hypothesizing that PB-CRD is non-inferior to CRD for weight loss. Methods: In this 12-week, open-label, non-inferiority trial, 80 participants with obesity (body mass index [BMI]: 28-40 kg/m Results: Of the 80 participants (mean BMI: 32.03 ± 3.46 kg/m Conclusion: Both PB-CRD and CRD were effective for weight loss, with PB-CRD demonstrating non-inferiority. Furthermore, PB-CRD offered superior benefits in reducing total body fat and improving uric acid metabolism, while improving insulin sensitivity and liver function in adults with obesity. Clinical trial registration: Identifier ChiCTR1800015156.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.